QNTM
FSD Pharma Class B Class B (Sub Voting)
Stock NASDAQ – Stock Market Prices, News & Analysis
FSD Pharma Inc is involved in the research and development of cannabis-based medications and other substances to treat chronic diseases.
FSD Pharma Class B Class B (Sub Voting)
QNTM
FSD Pharma Inc is involved in the research and development of cannabis-based medications and other substances to treat chronic diseases.
Price history of FSD Pharma Class B Class B (Sub Voting)
Price history of FSD Pharma Class B Class B (Sub Voting)
Performance & Momentum
Strategic Analysis
FSD Pharma Class B Class B (Sub Voting) • 2026
FSD Pharma Inc positions itself in the innovative niche of medical treatments based on cannabis and related substances, with a model focused on research and development to address the needs of chronic diseases. Its specialized approach aims to capture a growing segment in biotech health, despite a challenging competitive environment.
Strengths
- Strong expertise in medical research related to therapeutic cannabis
- Potential for developing innovative treatments for chronic diseases
Weaknesses
- Significantly degraded financial performance over the long term
- Lack of recent catalysts or favorable news to support the stock price
Momentum
The momentum of the stock is very weak, reflecting a disinterest from investors and a pronounced downward trend over several years. This context requires increased vigilance and suggests that clear signs of reversal will be necessary before any positive reassessment.
Similar stocks to FSD Pharma Class B Class B (Sub Voting)
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
